IDEAYA Biosciences, Inc. (IDYA) Revenue History
Annual and quarterly revenue from 2017 to present
IDYA Revenue Over Time (2017–2025)
IDYA Revenue Growth History
3 of 5 years with positive growth- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- +43.0%
- FY2022 revenue growth
- +82.3%
- FY2023 revenue growth
- -54.1%
- FY2024 revenue growth
- -70.1%
- FY2025 revenue growth
- +3024.4%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $6.6M | — |
| Q4 2025 | $10.9M | +55.4% |
| Q3 2025 | $207.8M | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $7.0M | +78.4% |
| Q3 2024 | $0 | -100.0% |
| Q2 2024 | $0 | -100.0% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
IDYA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
IDYA Revenue Analysis (2017–2025)
Current Revenue & Growth
As of June 29, 2026, IDEAYA Biosciences, Inc. (IDYA) generated trailing twelve-month (TTM) revenue of $225.3 million. The most recent quarter (Q1 2026) recorded $6.6 million in revenue, down 39.7% sequentially.
Historical Growth Trajectory
IDYA's 5-year compound annual growth rate (CAGR) stands at +62.1%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +62.5% is in line with the 5-year average, suggesting consistent growth. IDEAYA Biosciences, Inc.'s highest annual revenue of $218.7 million was recorded in 2025, an all-time high.
Revenue by Segment
IDYA's revenue is primarily driven by Research and Development Services (100%). With over half of revenue concentrated in Research and Development Services, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including TPVG, AGEN (+24.5% YoY), and KYMR (-12.6% YoY). Compare IDYA vs TPVG →
IDYA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IDYACurrent | $225M | - | +62.1% | -72.8% | |
 TPVG | $97M | - | - | 77.9% | |
 AGEN | $114M | +24.5% | +5.3% | -18.0% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% |
IDYA Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $218.7M | +3024.4% | $214.1M | 97.9% | $-159,313,000 | -72.8% |
| 2024 | $7.0M | -70.1% | $3.2M | 45.2% | $-326,975,000 | -4671.1% |
| 2023 | $23.4M | -54.1% | $19.4M | 82.9% | $-134,429,000 | -574.9% |
| 2022 | $50.9M | +82.3% | $48.8M | 95.9% | $-62,502,000 | -122.7% |
| 2021 | $27.9M | +43.0% | $26.2M | 93.8% | $-50,268,000 | -179.9% |
| 2020 | $19.5M | - | $18.2M | 92.9% | $-35,344,000 | -180.9% |
| 2019 | $0 | - | $-1,245,000 | - | $-44,271,000 | - |
| 2018 | $0 | - | $-886,000 | - | $-36,417,000 | - |
| 2017 | $0 | - | $-391,000 | - | $-14,438,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IDYA — Frequently Asked Questions
Quick answers to the most common questions about buying IDYA stock.
Is IDYA's revenue growth accelerating or slowing?
IDYA TTM revenue: $225M. YoY growth: N/A. 5-year CAGR: +62.1%.
What is IDYA's revenue history from 2017 to 2026?
IDEAYA Biosciences, Inc. (IDYA) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $225M, growing at N/A YoY. The 5-year CAGR is +62.1%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is IDYA's long-term revenue growth rate (CAGR)?
IDEAYA Biosciences, Inc.'s 5-year revenue CAGR of +62.1% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for IDYA.
Why does IDYA's quarterly revenue fluctuate?
IDYA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. IDEAYA Biosciences, Inc.'s revenue data from 2017 to 2026 shows full historical quarterly detail on this page.
How is IDYA's revenue distributed by segment?
IDYA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does IDYA's revenue compare to industry peers?
IDEAYA Biosciences, Inc. (IDYA) with TTM revenue of $225M and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.